ABSTRACT Does cGMP, via protein kinase G, inhibit cAMP-stimulated Ca 2ϩ current (I Ca(L) ) in mammalian ventricular myocytes by phosphorylating the calcium channel at a site different from that acted on by cAMP or by dephosphorylating the calcium channel through phosphatase(s)? We tested these possibilities in guinea pig ventricular myocytes superfused with Tyrode's solution (35°C) and dialyzed with adenosine 5Ј-O-(3-thiotriphosphate) ([ATP␥S] pip ). ATP␥S is a kinase substrate but thiophosphorylated proteins are not phosphatase substrates. With 5 mM [ATP␥S] pip , I Ca(L) increased gradually over 20 to 25 min and then rapidly in the presence of 3-isobutyl-1-methylxanthine. 8-Bromo-cGMP (8-Br-cGMP; 1 mM) did not inhibit I Ca(L) significantly (Ϫ3 Ϯ 11.8%, n ϭ 21) in contrast to results with ATP dialysis (Imai et al., 2001) . Similar results were obtained with 0.1 mM carbachol (CCh). I Ca(L) increased after longer dialysis (Ն40 min) with ATP␥S; again, 8-Br-cGMP had no effect. Also, isoproterenol (ISO) did not stimulate and CCh, alone or in the presence of ISO, did not inhibit I Ca(L) . Block of CCh effect by ATP␥S, although consistent with cGMP action in muscarinic inhibition, could be explained by guanosine 5Ј-O-(3-thiotriphosphate) (GTP␥S) formation from ATP␥S via nucleoside diphosphate kinase. GTP␥S uncouples muscarinic and ␤-adrenoceptors from intracellular effectors. Failure of 8-Br-cGMP to reduce I Ca(L) irreversibly excludes calcium channel phosphorylation as an inhibitory mechanism. We propose that cGMP inhibits I Ca(L) by activating phosphatase(s) in guinea pig ventricular myocytes.
Extrinsic regulation of heart function usually involves opposing actions by the autonomic nervous system. The yinyang hypothesis placed the postjunctional actions in the context of intracellular messengers, cAMP and cGMP, and their respective protein kinases having opposite effects on cellular processes (Watanabe and Besch, 1975) . One target, the Ltype calcium channel, has received considerable attention because the cAMP-activated protein kinase (PKA) increases current (I Ca(L) ) through the channel whereas the cGMP-activated kinase (PKG) decreases it (reviewed in McDonald et al., 1994) .
In mammalian ventricle, cGMP-inhibited phosphodiesterase (PDE) and PKG appear to be the principal effectors of cGMP with the former causing I Ca(L) to increase as it allows cAMP to accumulate (Ono and Trautwein, 1991; Shirayama and Pappano, 1996) . Activation of PKG, in the presence of elevated cAMP, inhibits the L-type calcium current but the proposed mechanisms differ. In rat ventricular myocytes, inhibition of I Ca(L) by cGMP was ascribed to phosphorylation by PKG of the L-type calcium channel or an associated regulatory protein (Méry et al., 1991; Sumii and Sperelakis, 1995) . When the ␣ 1c subunit of the cardiac calcium channel is expressed in oocytes, 8-bromo-cGMP (8-Br-cGMP) inhibited basal current (Jiang et al., 2000) . The PKG inhibitor KT5823 or replacement of serine by alanine at a consensus site (S533A) for PKG-dependent phosphorylation prevented inhibition by cGMP. In the ␣ 1c component of the L-type channel, PKA phosphorylates a serine residue 1928 (Gao et al., 1997) . Thus, antagonistic modulation of I Ca(L) by cyclic nucleotides could be referable to phosphorylation of different regulatory sites on the ␣ 1c subunit.
Activation of a phosphatase was excluded as a mechanism for inhibition by cGMP/PKG (Mé ry et al., 1991; Sumii and Sperelakis, 1995) . This conclusion is at odds with the observation that acetylcholine (ACh), which increases cGMP, opposed PKA-dependent phosphorylation of proteins in guinea pig ventricular myocytes (Gupta et al., 1994) . This was attributed to activation of protein phosphatase (PP). Okadaic acid, an inhibitor of PP, prevented dephosphorylation of proteins (Gupta et al., 1994) and inhibition of isoproterenol (ISO)-stimulated I Ca(L) by ACh . The phosphatase hypothesis was strengthened by evidence that inhibition of I Ca(L) by carbachol (CCh) or 8-Br-cGMP was antagonized by dialysis with 300 nM okadaic acid (Sakai et al., 1999) . As such, the results resemble those seen in GH 4 C 1 cells where atrial natriuretic peptide increased a maxi-K channel current by activating a phosphatase through a cGMP/PKG pathway (White et al., 1993) . Okadaic acid prevented maxi-K current stimulation by atrial natriuretic peptide. When Ba 2ϩ current through ␣ 1c subunits expressed in human embryonic kidney cells is elevated by forskolin-induced activation of adenylyl cyclase, phosphatase inhibition by okadaic acid potentiates this current and the phosphorylation of serine 1928 (Gao et al., 1997) .
We evaluated the phosphatase activation hypothesis for cGMP action on I Ca(L) . Our experiments were done with ATP␥S replacing ATP in the pipette solution [ATP␥S] pip ; 8-Br-cGMP was used to activate PKG. ATP␥S is a kinase substrate; the thiophosphorylated substrate resists phosphatase action (Yount, 1975) . With 3 mM [ATP␥S] pip , ISO increased I Ca(L) more than with ATP and the stimulant effect persisted when ISO was removed (Kameyama et al., 1985; Sipido et al., 1995) . PKA and PKG phosphorylate the L-type calcium channel at different sites. With ATP␥S present, we assume that if the effect of thiophosphorylation by PKA on I Ca(L) cannot be reversed by activation of PKG, the antagonistic interaction in ATP occurs by dephosphorylation of the site phosphorylated by cAMP/PKA. On the other hand, if cGMP can oppose the effect of cAMP on I Ca(L) in the presence of ATP␥S, the antagonism most likely occurs by thiophosphorylation of a different regulatory site on the ␣ 1c subunit.
Materials and Methods
Ventricular Myocyte Isolation. Single ventricular myocytes were isolated from the hearts of guinea pigs (250 -450 g) anesthetized with sodium pentobarbital (30 mg/kg, intraperitoneally) and anticoagulated with heparin (1000 IU, i.p.). The heart was perfused according to the Langendorff technique with modified Tyrode's solution containing 135 mM NaCl , 5.4 mM KCl, 1.8 mM CaCl 2 , 1.0 mM MgCl 2 , 0.33 mM NaH 2 PO 4 , 10 mM HEPES, and 20 mM glucose (pH was 7.4 with NaOH). The procedures are the same as we reported previously (Imai et al., 2001) . After collagenase and protease disrupted the extracellular matrix, the enzymes were washed out by perfusion with 50 ml of recovery solution containing 130 mM potassium aspartate, 5 mM K 2 ATP, 5 mM HEPES, and 20 mM glucose; pH was adjusted to 7.4 with KOH. The ventricles were removed, and the cells were dispersed in recovery solution and kept at 4°C for at least 1 h. A cell suspension droplet was placed in a chamber (500-l volume) on the stage of an inverted microscope. After 10 min, superfusion began with Tyrode's solution (2 ml/min) containing 10 mM glucose and 10 mM CsCl (35°C).
Electrophysiology. The patch rupture-whole cell voltage clamp technique used an EPC 7 patch-clamp amplifier (List Electronics, Darmstadt, Germany). Voltage commands and data acquisition were obtained with pClamp software (version 5.5; Axon Instruments, Union City, CA) and a Labmaster TL-1 interface (Axon Instruments). The pipette filling solution for glass electrodes (i.d.,1.1 mm; o.d.,1.3 mm) contained 135 to 140 mM cesium aspartate, 7 mM NaCl, 3.0 mM MgCl 2 , 3.5 or 5 mM ATP␥S, 10 mM EGTA, and 10 mM HEPES; pH 7.3 (with CsOH). In some experiments, the pipette solution also contained 1 mM GTP. The electrode resistance was 1 to 3 M⍀. Series resistance could be compensated up to 70% to values between 1 and 2.5 M⍀.
Membrane voltage was stepped from Ϫ80 to Ϫ40 mV for 300 ms to inactivate the fast Na ϩ and T-type Ca 2ϩ currents. A second voltage step to ϩ10 mV for 300 ms elicited I Ca(L) . The clamp protocol was repeated every 10 s. Drugs and Application. Drugs were applied to myocytes by superfusion by gravity from a reservoir. The applied solutions were warmed to provide an experimental temperature of 35°C. CCh, ISO, 8-Br-cGMP, and 3-isobutyl-1-methylxanthine (IBMX) were prepared fresh daily from aqueous stock solutions.
Data Analysis. With Cs ϩ -rich pipette solution to block membrane K ϩ currents, I Ca(L) is taken as peak current minus end-ofpulse current at ϩ10 mV. Measurements are reported as mean Ϯ S.E.M. The statistical significance of mean differences was determined by Student's t test. p Յ 0.05 was considered statistically significant.
Results
8-Br-cGMP inhibits I Ca(L) augmented by ISO or IBMX. At 0.1 mM, 8-Br-cGMP inhibited I Ca(L) in 0.1 mM IBMX by 34 Ϯ 3.6% and in 10 nM ISO by 32 Ϯ 7.1% (Imai et al., 2001) . Accordingly, one would expect 0.1 mM 8-Br-cGMP to suppress cAMP-stimulated I Ca(L) by about one-third. In the following experiments, a 10-fold greater concentration of 1 mM 8-Br-cGMP was used.
The results of a test with 8-Br-cGMP on IBMX-stimulated I Ca(L) are shown in Fig. 1 . The L-channel current was Ϫ0.7 nA upon patch rupture and gradually increased to Ϫ1.4 nA after 25 min, during which time the cell had been dialyzed with [ATP␥S] pip of 5 mM. In this experiment, the pipette solution also contained 1 mM GTP. Addition of 0.1 mM IBMX to the superfusion fluid markedly increased I Ca(L) to Ϫ4.6 nA at 30 min. When 1 mM 8-Br-cGMP was present for 5 min with IBMX, I Ca(L) remained at Ϫ4.6 nA. Washout of 8-Br-cGMP ensued and I Ca(L) remained elevated at Ϫ4.6 nA up to 40 min. This result is characteristic of that observed in a total of 21 cells in which 8-Br-cGMP was tested on cAMP-elevated I Ca(L) . In three of these cells, 10 nM ISO was used to stimulate I Ca(L) , and the results are included with those obtained with IBMX because the outcome was the same. Overall, the initial I Ca(L) just before addition of cAMP-elevating agent was Ϫ1.0 Ϯ 0.13 nA and it increased to Ϫ2.6 Ϯ 0.27 nA (n ϭ 21). On average, 1 mM 8-Br-cGMP changed cAMP-elevated I Ca(L) by Ϫ3 Ϯ 11.8% (n ϭ 21), which is not significantly different from 0. 8-Br-cGMP reduced I Ca(L) by Ϫ16 Ϯ 5.6% (n ϭ 8) in cells dialyzed with ATP␥S for Ͻ25 min, and by 5 Ϯ 18.7% (n ϭ 13) in cells dialyzed for Ͼ25 min (p ϭ 0.2). Importantly, if 8-Br-cGMP reduced IBMX-stimulated I Ca(L) , the effect was transient.
There were two cells in which we did not observe this pattern; an example is shown in Fig. 2 . The L-channel current increased from Ϫ1.4 to Ϫ2.8 nA during the first 10 min of dialysis; the pipette solution was the same as for the cell in Fig. 1 . Addition of 0.1 mM IBMX at 10 min had a small stimulant effect on I Ca(L) that eventually reached Ϫ3 nA at 16 min. When 1 mM 8-Br-cGMP was added, I Ca(L) diminished rapidly over the next 4 min to Ϫ0.4 nA. The current did not change appreciably over the ensuing 15 min when 8-BrcGMP and then IBMX were washed out. This result resembles that reported by Méry et al. (1991) in which cGMP irreversibly reduced cAMP-stimulated I Ca(L) . However, it is exceptional because it occurred in only 2 of the 23 cells tested and cannot be distinguished from rundown. In both instances, IBMX had been added at about 10 min after patch rupture and 8-Br-cGMP tested 5 min later. The time of IBMX addition ranged from 6 to 28 min with an average of 16 Ϯ 2 Inhibition of ISO-or IBMX-stimulated I Ca(L) by CCh has been reported by many investigators. We found that 0.1 mM CCh inhibited ISO-stimulated I Ca(L) by 77 Ϯ 7.9% and IBMXstimulated I Ca(L) by 79 Ϯ 6.3% (Imai et al., 2001 ). However, in cells dialyzed with ATP␥S, CCh had little effect when tested against IBMX-stimulated I Ca(L) . An example is shown in Fig. 3 . In this cell, I Ca(L) was Ϫ0.2 nA upon patch rupture and increased to Ϫ0.9 nA during the next 20 min as the cell was dialyzed with [ATP␥S] pip of 5 mM and [GTP] pip of 1 mM. Again, 0.1 mM IBMX, added at 20 min, promptly increased I Ca(L) to Ϫ5 nA (Fig. 3) . Current did not change upon addition of 0.1 mM CCh to the bath fluid for 5 min. When CCh was removed from the IBMX-containing solution, I Ca(L) remained at Ϫ5 nA through 40 min.
Overall, 0.1 mM CCh reduced cAMP-elevated I Ca(L) by Ϫ32 Ϯ 9.9% (n ϭ 12). Although this is substantially less than that observed with ATP in the pipette solution (see above), it is greater than the inhibition observed with 8-Br-cGMP in separate experiments. However, when both were tested in the same six cells against IBMX-stimulated I Ca(L) , CCh reduced current by Ϫ29 Ϯ 13.3% (32 Ϯ 5.2 min) and 8-Br-cGMP reduced it by Ϫ21 Ϯ 9.7% (26 Ϯ 7.1 min). In nine cells, we obtained stable recordings during dialysis with [ATP␥S] pip of 3.5 to 5 mM for Ն45 min. Under these conditions, tests with 1 mM 8-Br-cGMP 
Discussion
With PDEs inactivated by IBMX, we assume that there are two pathways for inhibition of I Ca(L) by cGMP/PKG, namely, phosphorylation of the ␣ 1c subunit that antagonizes the stimulant effect of cAMP/PKA and/or activation of PP that dephosphorylates the ␣ 1c subunit. Can 8-Br-cGMP or CCh suppress Ca 2ϩ current through L-type channels in the presence of ATP␥S, which allows kinases to thiophosphorylate substrates that resist phosphatase action? Irreversible suppression by 8-Br-cGMP would indicate that thiophosphorylation of the channel had occurred at a site different from that acted upon by cAMP/PKA (Méry et al., 1991; Sumii and Sperelakis, 1995) . Alternatively, failure of 8-Br-cGMP to suppress I Ca (L) in ATP␥S would indicate that the thiophosphorylated channel was resistant to phosphatase. Our results are consistent with the PP hypothesis for inhibition by cGMP of current through L-type channels in guinea pig ventricular myocytes.
Neurotransmitter regulation of I Ca(L) by reversible phosphorylation-dephosphorylation reactions is well known (McDonald et al., 1994; Herzig and Neumann, 2000) . Serine 1928 of the ␣ 1c subunit has been reported to be an essential residue for phosphorylation by PKA (Gao et al., 1997) . Our results point to the possibility that the site for phosphatase action on the ␣ 1c subunit is the same. This conclusion differs from that of others in several ways. Those who report that cGMP irreversibly inhibits I Ca(L) by phosphorylation of the channel did experiments in rat ventricular myocytes (Méry et al., 1991; Sumii and Sperelakis, 1995) . A similar conclusion emerged from experiments with mouse ventricular myocytes (Klein et al., 2000) . We did not observe suppression of basal I Ca(L) by 8-Br-cGMP unlike the results from rat ventricular myocytes (Sumii and Sperelakis, 1995) . Our experiments and those reporting cGMP/PKG-induced activation of PP are from guinea pig ventricular myocytes (reviewed in Herzig and Neumann, 2000) . Different species have distinct regulatory mechanisms for cGMP-dependent regulation of I Ca(L) . In amphibian ventricular myocytes, cGMP stimulated PDE, which reduces cAMP concentration (reviewed in Méry et al., 1997) . This pathway is not prominent in mammalian ventricular myocytes and would be inoperative in our experiments because IBMX inhibits all PDEs. In human atrial trabeculae, 8-Br-cGMP had a negative inotropic effect (Nawrath et al., 1995; Flesch et al., 1997) but increased I Ca(L) in single myocytes (Vandecasteele et al., 2001) . Stimulation of I Ca(L) by 8-Br-cGMP was attributed to activation of PKA. Although PKG was excluded as an effector of 8-Br-cGMP in single atrial myocytes (Vandecasteele et al., 2001) , it may have been the target in experiments with human atrial trabecular contractions (Nawrath et al., 1995; Flesch et al., 1997) . No information is available on effectors of 8-Br-cGMP in human ventricle, which conceivably differ from those in atrium ( Vandecasteele et al., 2001 ).
8-Br-cGMP could sometimes inhibit I Ca(L) in cells dialyzed for Յ25 min with ATP␥S. However, the inhibition was reversible, a finding inconsistent with cGMP/PKG causing irreversible inhibition via thiophosphorylation of the L-type calcium channel in rat ventricular myocytes (Méry et al., 1991) . In only 2 of 23 cells, 8-Br-cGMP addition was accompanied by a sustained decrease of I Ca(L) (Fig. 2) . Although this could be an example of irreversible inhibition, it cannot be distinguished from current rundown. Sufficient time should be allowed for diffusion of ATP␥S from the pipette solution and for replacing ATP for participation in thiophosphorylation reactions including those at the L-type calcium channel.
That ATP␥S interfered with inhibition of I Ca(L) by 8-BrcGMP favors the participation of PKG-activated PP in the cGMP signaling pathway. Dialysis with either PP1 or PP2A opposed ISO-stimulated I Ca(L) , but not basal I Ca(L) , in guinea pig ventricular myocytes (Hescheler et al., 1987) . Okadaic acid inhibits PP1 and PP2A with the latter being more sen- sitive (Herzig and Neumann, 2000) . Okadaic acid (300 nM in pipette solution) prevented inhibition of I Ca(L) by 8-Br-cGMP (Sakai et al., 1999) . That okadaic acid inhibits membrane bound PP1 and PP2A activities in guinea pig ventricular myocytes (Neumann et al., 1993) indicates that neither enzyme can be excluded from participating in I Ca(L) inhibition. Single channel recordings indicated that PP2A and PP1 dephosphorylate the L-type Ca 2ϩ channel at different sites (Ono and Fozzard, 1993; Wiechen et al., 1995) . Together with the present results, the data with okadaic acid favor activation of PP as a mechanism for cGMP/PKG signaling (see also White et al., 1993) .
ATP␥S Prevents Inhibition by Carbachol of I Ca(L) .
The ability of CCh to inhibit I Ca(L) diminished in cells dialyzed with ATP␥S. This is in accordance with the evidence that muscarinic agonist inhibits I Ca(L) by activating okadaic acid-sensitive PP and that cGMP is the signal molecule for this action (Imai et al., 2001) , presumably by phosphorylating PP (Sakai et al., 1999) . Similarly, ACh opposed the action of ISO or dibutyryl-cAMP on the inwardly rectifying K ϩ current by activation of okadaic acid-sensitive PP in guinea pig ventricular myocytes (Koumi et al., 1995) .
However, the effect of ATP␥S on the response to CCh may not be limited to interference with cGMP-stimulated PP activity. Thiophosphorylation of guanine nucleotides occurs when ATP␥S is present (Otero et al., 1988; Heidbü chel et al., 1990) . Dialysis with ATP␥S allows formation of GTP␥S from GDP via nucleoside diphosphate kinase, which is present in cardiac membranes (Heidbü chel et al., 1992) , and causes a sustained activation of ACh-activated K ϩ current (I K(ACh) ) in the absence of added guanine nucleotides. The effect of 1 mM ATP␥S is slow in onset but irreversible after about 20 min (Heidbü chel et al., 1990) . GTP␥S formed from ATP␥S not only activates I K(ACh) irreversibly but also uncouples G-protein-coupled receptors from intracellular effectors (Breitwieser and Szabo, 1985; Hescheler et al., 1986; Shirayama et al., 1993) . In atrial cells, a low concentration (0.4 mM) or brief exposure (4 min) to ATP␥S was associated with a partially reversible effect on I K(ACh) activation (Heidbü chel et al., 1992) .
Limitations. An alternative possibility is that cGMP/PKG not only activates PP but also phosphorylates the ␣ 1c subunit in guinea pig ventricular myocytes. That is, with ATP present, both reactions occur and contribute to suppression of cAMP/PKA-activated I Ca(L) . What happens in the presence of ATP␥S? With PP activity blocked, the most likely mechanism for inhibition is cGMP/PKG-induced thiophosphorylation of serine 533 on the ␣ 1c subunit. If this were so, one would have to conclude that these regulatory sites are not equal and that serine 1928 dominates because when thiophosphorylated by cAMP/PKA, thiophosphorylation of serine 533 by cGMP/PKG is unable to cause inhibition.
We assume that activation of PP by cGMP/PKG occurs at the same site on the ␣ 1c subunit as phosphorylation by cAMP/ PKA, namely, serine 1928. However, cAMP/PKA also phosphorylates the ␤ 2a subunit of the L-type Ca 2ϩ channel and this is suggested to regulate current through the pore-forming ␣ 1c subunit (Bü nemann et al., 1999) . However, it is not known if this occurs physiologically because the ␣ 1c subunit used in the experiments was truncated and lacked serine 1928.
Conceivably, a membrane-delimited pathway could allow GTP␥S, generated from ATP␥S, to activate the L-type channel via the ␣ subunit of the stimulatory guanine nucleotide-binding protein, G s (Yatani et al., 1987) . However, this pathway does not involve phosphorylation-dephosphorylation reactions. In summary, we conclude that inhibition of I Ca(L) by cGMP/PKG involves activation of PP in guinea pig ventricular myocytes and that dephosphorylation occurs at the site on ␣ 1c subunit phosphorylated by cAMP/PKA.
